Statistics
Publications
72
Citations
17.1K
H-Index
35
Active since
2007
Peng Jiang is an author at Dana-Farber Cancer Institute specializing in life sciences, oncology, and medicine.
Publications per year
2007–2025
72
72
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang, Shengqing Gu, Deng Pan et al. · Nature Medicine · 2018 · 5.6K citations · Full text
Life Sciences, Immunology, Oncology +14
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li, Eric A. Severson, Jean‐Christophe Pignon et al. · Genome biology · 2016 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +17
Expanded encyclopaedias of DNA elements in the human and mouse genomes
Federico Abascal, Reyes Acosta, Nicholas J. Addleman et al. · Nature · 2020 · 2.6K citations · Full text
Large-scale public data reuse to model immunotherapy response and resistance
Jingxin Fu, Karen Li, Wubing Zhang et al. · Genome Medicine · 2020 · 1.1K citations · Full text
Medicine, Bioinformatics, Oncology +17
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
Deng Pan, Aya Kobayashi, Peng Jiang et al. · Science · 2018 · 864 citations
Medicine, Immunology, Oncology +16
1–5 of 72